CEPI (Coalition for Epidemic Preparedness Innovations) Disease X Programme Lead Dr Timothy Endy spoke to The BREAK— DOWN about prioritising vaccine development efforts against the highest pandemic potential viral families across the 25 or more known viral families.
Public source
Publisher name
Public post
The "Disease X" concept raises awareness that there is something coming at some point in the future -- but we don't yet know what it may be. So how do you prepare for th…
Company
CEPI (Coalition for Epidemic Preparedness Innovations)
We want to stop future epidemics by developing new vaccines for a safer world.
- Industry
- Research Services
- Location
- Oslo, NO
- Company size
- 501–1,000 employees
About CEPI (Coalition for Epidemic Preparedness Innovations)
CEPI is an innovative partnership between public, private, philanthropic and civil organisations. Its mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. Central to CEPI’s pandemic-beating plan is the ‘100 Days Mission’ – its goal to develop safe, effective and accessible vaccines against new threats in just 100 days. CEPI is seeking $2.5 billion to execute CEPI 3.0, its 2027-2031 strategy, which will systematically reduce the likelihood, impact and cost of epidemics and pandemics by driving the 100 Days Mission towards an operational reality. Learn more at CEPI.net.
See moreLatest activity
Latest activity from CEPI (Coalition for Epidemic Preparedness Innovations)
13 signals
Research & Knowledge
CEPI (Coalition for Epidemic Preparedness Innovations) is partnering with Impact Global Health to generate evidence of how biosafety and biosecurity are funded and accounted for in global health R&D settings.
Presence & Recognition
CEPI (Coalition for Epidemic Preparedness Innovations) hosted a pandemic simulation exercise in Jakarta, Indonesia, featuring over 120 experts working across the vaccine and epidemic preparedness research ecosystem to discuss collaboration and leverage Indonesia's pandemic preparedness capability.
Strategy & Corporate Development
CEPI (Coalition for Epidemic Preparedness Innovations) launched CEPI 3.0, a new strategy to shift from reacting to outbreaks to preparing for them.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
NIH Innovates
NIH Innovates published a study in Nature Microbiology comparing two experimental Zika vaccines in mice to gain insights into developing vaccines against Zika and similar viruses.
Research & Knowledge
Drugs for Neglected Diseases initiative (DNDi)
Drugs for Neglected Diseases initiative (DNDi) is currently developing a specific treatment to prevent the progression of the disease to severe dengue
Research & Knowledge
Helmholtz Centre for Infection Research
Helmholtz Centre for Infection Research researcher Mark Broenstrup and his team are developing a novel antibiotic that neutralizes a toxin produced by S. aureus.
Research & Knowledge
Center for Infectious Disease Research and Policy (CIDRAP)
Center for Infectious Disease Research and Policy (CIDRAP) published a review of COVID-19 vaccine safety and effectiveness screening over 11,000 studies, identifying 155 eligible studies for inclusion.
Research & Knowledge
The Pirbright Institute